A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Astrana Health, Inc.
ASTH
$2.0B
Mkt Cap
$40.31
-1.66%
Astrana Health, Inc. (ASTH) has a current P/E ratio of 212.2, compared to its historical median P/E of 30.8. The stock is currently considered Expensive based on its historical valuation range.
Astrana Health, Inc. (ASTH) has a 5-year average return on invested capital (ROIC) of 7.1%. This is below average and may indicate limited pricing power.
Astrana Health, Inc. (ASTH) has a market capitalization of $2.0B. It is classified as a small-cap stock.
Yes, Astrana Health, Inc. (ASTH) pays a dividend with a trailing twelve-month yield of 0.40%. The company also returns capital through share buybacks, with a buyback yield of 1.30%.
Based on historical P/E analysis, Astrana Health, Inc. (ASTH) appears expensive. The current P/E of 212.2 is 589% above its historical median of 30.8. The estimated fair value CAGR (P/E method) is 4.9%.
Astrana Health, Inc. (ASTH) operates in the Services-Management Consulting Services industry, within the Industrials sector.
Astrana Health, Inc. (ASTH) reported annual revenue of $3.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
Astrana is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. We, together with our affiliated physician groups and consolidated subsidiaries and VIEs, provide coordinated outcome-based care, serving patients covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (“HMOs”), with a small portion of our revenue coming from non-insured patients. We provide care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.2B | 3.2B | 2.0B | 1.4B | 1.1B | 774M |
| Net Income | 22M | 22M | 43M | 61M | 45M | 69M |
| EPS | $0.46 | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 |
| Free Cash Flow | 104M | 104M | 44M | 40M | 59M | 51M |
| ROIC | 1.9% | 2.5% | 5.0% | 6.9% | 10.3% | 10.7% |
| Gross Margin | 12.3% | 12.3% | 15.0% | 16.7% | 18.1% | 23.0% |
| Debt/Equity | 2.73 | 2.73 | 1.28 | 0.98 | 0.80 | 0.86 |
| Dividends/Share | $0.16 | $0.16 | $0.08 | $1.32 | $0.31 | $0.69 |
| Operating Income | 79M | 79M | 89M | 85M | 104M | 98M |
| Operating Margin | 2.5% | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% |
| ROE | 2.9% | 3.0% | 6.5% | 10.5% | 9.1% | 17.7% |
| Shares Outstanding | 49M | 49M | 48M | 47M | 46M | 45M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 10M | 33M | 306M | 356M | 520M | 561M | 687M | 774M | 1.1B | 1.4B | 2.0B | 3.2B | 3.2B |
| Gross Margin | 13.4% | 33.1% | 16.7% | 23.3% | 30.5% | 16.6% | 21.5% | 23.0% | 18.1% | 16.7% | 15.0% | 12.3% | 12.3% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 5.3M | 11M | 21M | 26M | 43M | 41M | 49M | 62M | 78M | 113M | 154M | 217M | 217M |
| EBIT | -3.9M | -694K | 12M | 35M | 88M | 32M | 81M | 98M | 104M | 85M | 89M | 79M | 79M |
| Op. Margin | -37.3% | -2.1% | 3.8% | 9.9% | 17.0% | 5.8% | 11.7% | 12.7% | 9.1% | 6.1% | 4.4% | 2.5% | 2.5% |
| Net Income | -5.0M | -1.8M | 11M | 26M | 11M | 14M | 38M | 69M | 45M | 61M | 43M | 22M | 22M |
| Net Margin | -47.9% | -5.5% | 3.7% | 7.2% | 2.1% | 2.5% | 5.5% | 8.9% | 3.9% | 4.4% | 2.1% | 0.7% | 0.7% |
| Non-Recurring | 0 | 0 | 317K | 68K | 3.8M | 3.8M | -91K | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -78.0% | -3.7% | 16.6% | 58.7% | 85.2% | 8.0% | 10.6% | 10.7% | 10.3% | 6.9% | 5.0% | 2.5% | 1.9% |
| ROE | 337.6% | 66.3% | 27.1% | 20.9% | 6.4% | 7.6% | 14.4% | 17.7% | 9.1% | 10.5% | 6.5% | 3.0% | 2.9% |
| ROA | -139.8% | -19.0% | 6.3% | 6.1% | 2.2% | 2.3% | 4.9% | 8.2% | 4.9% | 6.4% | 3.8% | 1.3% | 1.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -1.5M | -272K | 22M | 52M | 25M | 14M | 46M | 70M | 82M | 68M | 52M | 115M | 115M |
| Free Cash Flow | -1.5M | -316K | 19M | 50M | 24M | 13M | 45M | 51M | 59M | 40M | 44M | 104M | 104M |
| Owner Earnings | -1.5M | -1.9M | 1.8M | 30M | 4.8M | -6.2M | 24M | 46M | 48M | 28M | -10M | 30M | 30M |
| CapEx | 23K | 45K | 3.3M | 2.1M | 1.2M | 1.0M | 1.2M | 19M | 23M | 29M | 8.0M | 10M | 10M |
| Maint. CapEx | 31K | 334K | 18M | 19M | 19M | 18M | 18M | 18M | 18M | 18M | 28M | 46M | 46M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.7M | 5.4M | 11M | 0 | 0 | 0 |
| D&A | 31K | 334K | 18M | 19M | 19M | 18M | 18M | 18M | 18M | 18M | 28M | 46M | 46M |
| CapEx/OCF | N/A | N/A | 15.1% | 4.0% | 4.6% | 7.6% | 2.5% | 27.3% | 27.9% | 41.8% | 15.4% | N/A | 8.8% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 27M | 10M | 18M | 62M | 51M | 31M | 14M | 62M | 4.0M | 7.9M | 7.9M |
| Dividend Yield | N/A | N/A | 3.8% | 0.7% | 2.4% | 9.6% | 8.2% | 1.2% | 0.7% | 3.9% | 0.2% | N/A | 0.4% |
| Share Buybacks | 0 | 0 | 518K | 3.2M | 5.0M | 7.6M | 537K | 5.7M | 9.3M | 100M | 900K | 26M | 26M |
| Buyback Yield | N/A | N/A | 0.9% | 0.5% | 0.7% | 1.1% | 0.1% | 0.2% | 0.7% | N/A | N/A | 0.0% | 1.3% |
| Stock-Based Comp | 13K | 1.3M | 2.0M | 2.7M | 1.4M | 1.5M | 3.4M | 6.7M | 16M | 22M | 35M | 39M | 39M |
| Debt Repayment | 258K | 534K | 181K | 0 | 0 | 2.4M | 0 | 208K | 561K | 205M | 19M | 495M | 495M |
| Balance Sheet | |||||||||||||
| Net Debt | -5.7M | -47M | -56M | -81M | -103M | 284M | 245M | 101M | 141M | 305M | 618M | 1.7B | 1.7B |
| Cash & Equiv. | 6.8M | 59M | 55M | 100M | 107M | 103M | 193M | 233M | 288M | 294M | 288M | 429M | 429M |
| Long-Term Debt | 1.1M | 11M | 0 | 5.0M | 0 | 232M | 230M | 183M | 203M | 259M | 425M | 991M | 991M |
| Debt/Equity | -0.42 | -4.31 | 0.00 | 0.12 | 0.03 | 2.63 | 1.53 | 0.86 | 0.80 | 0.98 | 1.28 | 2.73 | 2.73 |
| Interest Coverage | -5.8 | -0.5 | 189.8 | 441.0 | 157.6 | 6.8 | 8.5 | 18.2 | 13.2 | 5.3 | 2.7 | 1.6 | 1.6 |
| Equity | -2.6M | -2.8M | 87M | 160M | 181M | 192M | 331M | 448M | 543M | 614M | 713M | 779M | 779M |
| Total Assets | 4.0M | 15M | 350M | 491M | 513M | 729M | 817M | 867M | 966M | 933M | 1.4B | 2.2B | 2.2B |
| Total Liabilities | 6.6M | -70M | 100M | 154M | 106M | 368M | 372M | 357M | 408M | 523M | 841M | 1.7B | 1.7B |
| Intangibles | 1.4M | 1.4M | 108M | 104M | 87M | 103M | 87M | 83M | 77M | 72M | 118M | 271M | 271M |
| Retained Earnings | -17M | -19M | -773K | 1.7M | 18M | 32M | 70M | 137M | 182M | 243M | 286M | 308M | 308M |
| Working Capital | -1.4M | 3.9M | 31M | 35M | 101M | 224M | 224M | 290M | 280M | 243M | 273M | 248M | 248M |
| Current Assets | 3.1M | 9.9M | 81M | 144M | 173M | 329M | 339M | 404M | 428M | 462M | 638M | 863M | 863M |
| Current Liabilities | 4.6M | 6.0M | 51M | 110M | 72M | 105M | 115M | 115M | 149M | 219M | 366M | 615M | 615M |
| Per Share Data | |||||||||||||
| EPS | -2.74 | -0.74 | 0.08 | 0.18 | 0.29 | 0.39 | 1.01 | 1.52 | 0.99 | 1.29 | 0.90 | 0.46 | 0.46 |
| Owner EPS | -0.83 | -0.77 | 0.01 | 0.21 | 0.13 | -0.17 | 0.65 | 1.02 | 1.06 | 0.60 | -0.21 | 0.62 | 0.62 |
| Book Value | -1.43 | -1.16 | 0.62 | 1.12 | 4.83 | 5.29 | 8.87 | 9.88 | 11.89 | 13.05 | 14.87 | 15.94 | 15.94 |
| Cash Flow/Share | -0.81 | -0.11 | 0.16 | 0.36 | 0.68 | 0.38 | 1.24 | 1.55 | 1.80 | 1.45 | 1.09 | 2.34 | 1.40 |
| Dividends/Share | N/A | N/A | 0.19 | 0.07 | 0.48 | 1.71 | 1.38 | 0.69 | 0.31 | 1.32 | 0.08 | 0.16 | 0.16 |
| Shares Out. | 1.8M | 2.4M | 139.7M | 143.3M | 37.4M | 36.2M | 37.3M | 45.3M | 45.6M | 47.1M | 47.9M | 48.9M | 48.9M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | 19.5 | 26.7 | 71.5 | 47.8 | 17.5 | 47.1 | 29.0 | 30.8 | 36.4 | N/A | 87.6 |
| P/FCF | N/A | N/A | 60.1 | 69.2 | 31.8 | 53.4 | 14.6 | 63.5 | 22.1 | 47.1 | 35.5 | N/A | 18.9 |
| EV/EBIT | N/A | N/A | N/A | 16.7 | 7.5 | 21.5 | 8.0 | 32.0 | 11.7 | 21.9 | 19.2 | N/A | 46.8 |
| Price/Book | N/A | N/A | 0.6 | 4.3 | 4.3 | 3.5 | 2.0 | 7.2 | 2.4 | 3.0 | 2.2 | N/A | 2.5 |
| Price/Sales | 1.8 | 0.9 | 0.1 | 0.8 | 1.4 | 1.1 | 0.9 | 3.3 | 1.7 | 1.2 | 1.0 | N/A | 0.6 |
| FCF Yield | -9.3% | -1.2% | 33.5% | 7.2% | 3.1% | 1.9% | 6.8% | 1.6% | 4.5% | 2.1% | 2.8% | N/A | 5.3% |
| Market Cap | 16M | 26M | 56M | 688M | 775M | 675M | 661M | 3.2B | 1.3B | 1.9B | 1.6B | 0 | 2.0B |
| Avg. Price | 5.08 | 6.00 | 5.04 | 9.82 | 19.42 | 17.75 | 16.83 | 56.71 | 42.47 | 34.20 | 43.97 | 0.00 | 40.31 |
| Year-End Price | 4.40 | 5.25 | 8.00 | 24.00 | 20.73 | 18.65 | 17.64 | 71.53 | 28.71 | 39.70 | 32.72 | 0.00 | 40.31 |
Astrana Health, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
Astrana Health, Inc. trades at 212.2x trailing earnings, compared to its 15-year median P/E of 30.8x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 23.4x vs a median of 47.1x. The company's 5-year average ROIC is 7.1% with a gross margin of 17.0%. Total shareholder yield (dividends + buybacks) is 1.7%. At current prices, the estimated annualized return to fair value is +10.9%.
Astrana Health, Inc. (ASTH) has a net profit margin of 0.7%. This is a modest margin.
Astrana Health, Inc. (ASTH) generated $104 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Astrana Health, Inc. (ASTH) has a debt-to-equity ratio of 2.73. This indicates higher leverage, which may increase financial risk.
Astrana Health, Inc. (ASTH) reported earnings per share (EPS) of $0.46 in its most recent fiscal year.
Astrana Health, Inc. (ASTH) has a return on equity (ROE) of 3.0%. This indicates moderate shareholder returns.
Astrana Health, Inc. (ASTH) has a 5-year average gross margin of 17.0%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 15 years of financial data for Astrana Health, Inc. (ASTH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Astrana Health, Inc. (ASTH) has a book value per share of $15.94, based on its most recent annual SEC filing.